Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  HIV Infection

  Free Subscription


19.12.2022

8 AIDS
7 AIDS Res Hum Retroviruses
2 Am J Med
2 BMJ
3 Clin Infect Dis
1 HIV Med
1 Int J Cancer
3 J Acquir Immune Defic Syndr
2 J Am Acad Dermatol
1 J Clin Invest
2 J Infect Dis
2 J Med Virol
4 J Virol
1 JAMA
1 Lancet
1 Lancet Infect Dis
2 N Engl J Med
1 Nat Med
1 Nature
2 PLoS Med
8 PLoS One
1 PLoS Pathog
2 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. DOUGLAS PS, Mccallum S, Lu MT, Umbleja T, et al
    Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV.
    AIDS. 2022 Nov 18. doi: 10.1097/QAD.0000000000003418.
    PubMed         Abstract available

  2. SCHRUBBE LA, Stockl H, Hatcher AM, Marston M, et al
    Prevalence and risk factors of unsuppressed viral load among pregnant and breastfeeding women in sub-Saharan Africa: analysis from population-based surveys.
    AIDS. 2022 Dec 12. doi: 10.1097/QAD.0000000000003459.
    PubMed         Abstract available

  3. PERNA A, Carleo MA, Mascolo S, Guida A, et al
    Adipocyte differentiation of 3T3-L1 cells under TAF, TDF and INSTIs selective challenge: an in vitro model.
    AIDS. 2022 Dec 13. doi: 10.1097/QAD.0000000000003455.
    PubMed         Abstract available

  4. KUHN S, Klinker H, Umland T, Baier M, et al
    Viral break through during dolutegravir-based antiretroviral therapy after excessive consumption of fruit juices.
    AIDS. 2023;37:200-203.
    PubMed        

  5. HORNER MJ, Hazra R, Barnholtz-Sloan JS, Shiels MS, et al
    Cancer risk among HIV-exposed uninfected children in the United States.
    AIDS. 2022 Dec 23. doi: 10.1097/QAD.0000000000003458.
    PubMed         Abstract available

  6. ZINO L, Jacobs TG, Nieuwenstein T, Grintjes K, et al
    Model-informed intermittent tenofovir disoproxil fumarate and emtricitabine dosing for HIV pre-exposure prophylaxis in subjects with renal impairment: a case report.
    AIDS. 2023;37:363-365.
    PubMed        

  7. ALIYU GG, Lawton JG, Mitchell AB, Abimiku AG, et al
    Prevalence of HIV drug resistance in Nigeria: results from a cross-sectional, population-based survey of Nigerian adults with unsuppressed viral load.
    AIDS. 2023;37:333-339.
    PubMed         Abstract available

  8. HANTTU AM, Pekkala S, Satokari R, Hartikainen AK, et al
    Gut microbiota alterations after switching from a protease inhibitor or efavirenz to raltegravir in a randomized, controlled study.
    AIDS. 2023;37:323-332.
    PubMed         Abstract available


    AIDS Res Hum Retroviruses

  9. WILSON A, Manuzak J, Liang H, Leda AR, et al
    Probiotic therapy during vaccination alters antibody response to SHIV infection but not to commensals.
    AIDS Res Hum Retroviruses. 2022 Dec 14. doi: 10.1089/AID.2022.0123.
    PubMed         Abstract available

  10. TAO K, Rhee SY, Tzou PL, Holmes S, et al
    Highly Ambiguous HIV-1 pol Positions Encoding Multiple Amino Acids Usually Result from Antiviral or Immune Selection Pressure.
    AIDS Res Hum Retroviruses. 2022 Dec 14. doi: 10.1089/AID.2022.0094.
    PubMed         Abstract available

  11. SINGTOROJ T, Teeraananchai S, Chokephaibulkit K, Phanuphak N, et al
    Factors associated with morbidity and mortality among sexually active Asian adolescents and young adults with perinatally acquired HIV.
    AIDS Res Hum Retroviruses. 2022 Dec 14. doi: 10.1089/AID.2021.0169.
    PubMed         Abstract available

  12. WALMSLEY S, Clarke R, Lee T, Singer J, et al
    BEING: Bone Health in Aging Women with HIV: Impact of Switching Antiretroviral Therapy on Bone Mineral Density During the Peri-menopausal period.
    AIDS Res Hum Retroviruses. 2022 Dec 13. doi: 10.1089/AID.2022.0106.
    PubMed         Abstract available

  13. BRICENO O, Peralta-Prado A, Garrido-Rodriguez D, Romero-Mora K, et al
    Double negative T cell number and phenotype alterations before and after effective antiretroviral treatment in persons living with HIV.
    AIDS Res Hum Retroviruses. 2022 Dec 13. doi: 10.1089/AID.2022.0047.
    PubMed         Abstract available

  14. MISHRA S, Taneja S, De A, Verma N, et al
    Efficacy, tolerability and compliance of direct acting antivirals in patients with HIV and Hepatitis C co-infection: A real-life experience.
    AIDS Res Hum Retroviruses. 2022 Dec 13. doi: 10.1089/AID.2022.0034.
    PubMed         Abstract available

  15. PUCCIONI-SOHLER M, Poton AR, Cabral-Castro MJ, Yamano Y, et al
    Human T Lymphotropic Virus 1-Associated Myelopathy: Overview of Human T Cell Lymphotropic Virus-1/2 Tests and Potential Biomarkers.
    AIDS Res Hum Retroviruses. 2022;38:924-932.
    PubMed         Abstract available


    Am J Med

  16. KLOTZ SA, Chan CB, Bianchi S, Egurrola C, et al
    The Genie is out of the Bottle: Telemedicine is More Effective than Brick-and-Mortar Clinics in the Care of HIV-infected Outpatients.
    Am J Med. 2022 Dec 7:S0002-9343(22)00880-4. doi: 10.1016/j.amjmed.2022.
    PubMed        

  17. SALCEDO RM, Madariaga MG
    Monkeypox (hMPXV infection): A practical review.
    Am J Med. 2022 Dec 7:S0002-9343(22)00875-0. doi: 10.1016/j.amjmed.2022.
    PubMed         Abstract available


    BMJ

  18. RAHANGDALE L, Mungo C, O'Connor S, Chibwesha CJ, et al
    Human papillomavirus vaccination and cervical cancer risk.
    BMJ. 2022;379:e070115.
    PubMed         Abstract available

  19. ANDERSON J, Fenton K
    HIV related stigma: a dangerous roadblock.
    BMJ. 2022;379:o2989.
    PubMed        


    Clin Infect Dis

  20. SALAHUDDIN S, Cohen O, Wu M, Perez Irizarry J, et al
    HIV is associated with poor overall survival among head and neck cancer patients.
    Clin Infect Dis. 2022 Dec 15:ciac924. doi: 10.1093.
    PubMed         Abstract available

  21. BOSCH B, Akpomiemie G, Chandiwana N, Sokhela S, et al
    Weight and metabolic changes after switching from tenofovir alafenamide (TAF)/emtricitabine (FTC)+dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)/FTC+DTG and TDF/FTC/efavirenz (EFV) to TDF/lamivudine (3TC)/DTG.
    Clin Infect Dis. 2022 Dec 15:ciac949. doi: 10.1093.
    PubMed         Abstract available

  22. WANG Y, Noel-Romas L, Perner M, Knodel S, et al
    Non-Lactobacillus dominant and polymicrobial vaginal microbiomes are more common in younger South African women and predictive of increased risk of HIV acquisition.
    Clin Infect Dis. 2022 Dec 12:ciac938. doi: 10.1093.
    PubMed         Abstract available


    HIV Med


  23. BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022.
    HIV Med. 2022;23 Suppl 5:3-115.
    PubMed        


    Int J Cancer

  24. BOUCHERON P, Anele A, Offiah AU, Zietsman A, et al
    Reproductive history and breast cancer survival: findings from the African Breast Cancer - Disparities in Outcomes cohort and implications of Africa's fertility transition on breast cancer prognosis.
    Int J Cancer. 2022 Dec 22. doi: 10.1002/ijc.34411.
    PubMed         Abstract available


    J Acquir Immune Defic Syndr

  25. BLAIR CS, Fulcher JA, Cho GD, Gorbach PM, et al
    Impact of Methamphetamine Use and Rectal STIs on Systemic and Rectal Mucosal Inflammation.
    J Acquir Immune Defic Syndr. 2022 Dec 14. doi: 10.1097/QAI.0000000000003143.
    PubMed         Abstract available

  26. WOLFE HL, Drainoni ML, Klasko-Foster L, Fix GM, et al
    Structural Equation Modeling of Stigma and HIV Prevention Clinical Services Among Transgender and Gender Diverse Adults: The Mediating Role of Substance Use and HIV Sexual Risk.
    J Acquir Immune Defic Syndr. 2022 Dec 14. doi: 10.1097/QAI.0000000000003144.
    PubMed         Abstract available

  27. VIGUERIE A, Song R, Johnson AS, Lyles CM, et al
    Isolating the effect of COVID-19 related disruptions on HIV diagnoses in the United States in 2020.
    J Acquir Immune Defic Syndr. 2022 Dec 14. doi: 10.1097/QAI.0000000000003140.
    PubMed         Abstract available


    J Am Acad Dermatol

  28. MARKS DH, Mansh MD
    Comment on "Risk of skin cancer in HIV-infected patients: A Danish nationwide cohort study".
    J Am Acad Dermatol. 2023;88:e17-e18.
    PubMed        

  29. OMLAND SH, Omland LH
    Reply to: "Comment on 'Risk of skin cancer in HIV-infected patients: A Danish nationwide cohort study'".
    J Am Acad Dermatol. 2023;88:e15.
    PubMed        


    J Clin Invest

  30. KIM JT, Zack JA
    A humanized mouse model to study NK cell biology during HIV infection.
    J Clin Invest. 2022;132:e165620.
    PubMed         Abstract available


    J Infect Dis

  31. TOVINH M, Horr G, Hoffmeister C, Dobrikova K, et al
    HIV-associated microbial translocation may affect cytokine production of CD56bright NK cells via stimulation of monocytes.
    J Infect Dis. 2022 Dec 15:jiac485. doi: 10.1093.
    PubMed         Abstract available

  32. DONNELLAN S, Pennington SH, Ruggiero A, Martinez-Rodriguez C, et al
    A quantitative method for the study of HIV-1 and Mycobacterium tuberculosis co-infection.
    J Infect Dis. 2022 Dec 20:jiac491. doi: 10.1093.
    PubMed         Abstract available


    J Med Virol

  33. SANTINELLI L, Rossi G, Gioacchini G, Verin R, et al
    The crosstalk between gut barrier impairment, mitochondrial dysfunction and microbiota alterations in people living with HIV.
    J Med Virol. 2022 Dec 14. doi: 10.1002/jmv.28402.
    PubMed         Abstract available

  34. GU L, Lin E, Liu S, Yang N, et al
    Efficacy of Immunotherapy with Combination of Cryotherapy and Topical Imiquimod for Treatment of Kaposi Sarcoma.
    J Med Virol. 2022 Dec 12. doi: 10.1002/jmv.28396.
    PubMed         Abstract available


    J Virol

  35. KIM S, Filsinger Interrante MV, Kim PS
    Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies.
    J Virol. 2022 Dec 21:e0164722. doi: 10.1128/jvi.01647.
    PubMed         Abstract available

  36. CHEN Y, Wu Y, Chen S, Zhan Q, et al
    Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein.
    J Virol. 2022 Dec 5:e0124522. doi: 10.1128/jvi.01245.
    PubMed         Abstract available

  37. MATSUMOTO K, Kuwata T, Tolbert WD, Richard J, et al
    Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates.
    J Virol. 2022 Dec 13:e0163822. doi: 10.1128/jvi.01638.
    PubMed         Abstract available

  38. WOOLLEY G, Mosher M, Kroll K, Jones R, et al
    Natural Killer Cells Regulate Acute SIV Replication, Dissemination, and Inflammation, but Do Not Impact Independent Transmission Events.
    J Virol. 2022 Dec 13:e0151922. doi: 10.1128/jvi.01519.
    PubMed         Abstract available


    JAMA

  39. KUEHN BM
    Early Treatment Recommended for Patients With HIV and Monkeypox.
    JAMA. 2022;328:2203.
    PubMed        


    Lancet

  40. SAMARASEKERA U
    Pakistan's growing HIV epidemic.
    Lancet. 2022;400:2031.
    PubMed        


    Lancet Infect Dis

  41. SUNER C, Ubals M, Tarin-Vicente EJ, Mendoza A, et al
    Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain.
    Lancet Infect Dis. 2022 Dec 12:S1473-3099(22)00794.
    PubMed         Abstract available


    N Engl J Med

  42. KIEH M, Richert L, Beavogui AH, Grund B, et al
    Randomized Trial of Vaccines for Zaire Ebola Virus Disease.
    N Engl J Med. 2022 Dec 14. doi: 10.1056/NEJMoa2200072.
    PubMed         Abstract available

  43. NYANG'WA BT, Berry C, Kazounis E, Motta I, et al
    A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
    N Engl J Med. 2022;387:2331-2343.
    PubMed         Abstract available


    Nat Med

  44. KEUROGHLIAN AS, Keatley J, Shaikh S, Radix AE, et al
    The context, science and practice of gender-affirming care.
    Nat Med. 2022 Dec 15. doi: 10.1038/s41591-022-02082.
    PubMed        


    Nature

  45. CAO Y, Jian F, Wang J, Yu Y, et al
    Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution.
    Nature. 2022 Dec 19. doi: 10.1038/s41586-022-05644.
    PubMed         Abstract available


    PLoS Med

  46. SILVA S, Ayoub HH, Johnston C, Atun R, et al
    Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: A modeling study.
    PLoS Med. 2022;19:e1003938.
    PubMed         Abstract available

  47. KAAYA S, Siril H, Fawzi MCS, Aloyce Z, et al
    A peer-facilitated psychological group intervention for perinatal women living with HIV and depression in Tanzania-Healthy Options: A cluster-randomized controlled trial.
    PLoS Med. 2022;19:e1004112.
    PubMed         Abstract available


    PLoS One

  48. TOMKO C, Clouse E, Haney K, Galai N, et al
    A study protocol to explore and implement community-based point-of-care COVID-19 testing for women who use drugs in Baltimore, Maryland: The CARE study.
    PLoS One. 2022;17:e0277605.
    PubMed         Abstract available

  49. TENAW LA, Aragie MW, Ayele AD, Kokeb T, et al
    Medical and psychological consequences of rape among survivors during armed conflicts in northeast Ethiopia.
    PLoS One. 2022;17:e0278859.
    PubMed         Abstract available


  50. Expression of Concern: Metabarcoding analysis of eukaryotic microbiota in the gut of HIV-infected patients.
    PLoS One. 2022;17:e0278360.
    PubMed        

  51. MOHAMMADEBRAHIMI S, Kiani B, Rahmatinejad Z, Baral S, et al
    Geospatial epidemiology of hospitalized patients with a positive influenza assay: A nationwide study in Iran, 2016-2018.
    PLoS One. 2022;17:e0278900.
    PubMed         Abstract available

  52. DOGBA MJ, Bila A, Serme L, Bicaba A, et al
    Towards a deeper understanding of male involvement in the prevention of mother to child transmission of HIV in the Bogodogo District of the Central Region of Burkina Faso.
    PLoS One. 2022;17:e0277171.
    PubMed         Abstract available

  53. NICASTRO TM, Pincus L, Weke E, Hatcher AM, et al
    Perceived impacts of a pilot agricultural livelihood and microfinance intervention on agricultural practices, food security and nutrition for Kenyans living with HIV.
    PLoS One. 2022;17:e0278227.
    PubMed         Abstract available

  54. MVALO T, Smith AG, Eckerle M, Hosseinipour MC, et al
    Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis.
    PLoS One. 2022;17:e0278938.
    PubMed         Abstract available

  55. DRILLIEN R, Pradeau-Aubreton K, Batisse J, Mezher J, et al
    Efficient production of protein complexes in mammalian cells using a poxvirus vector.
    PLoS One. 2022;17:e0279038.
    PubMed         Abstract available


    PLoS Pathog

  56. ALVES E, Al-Kaabi M, Keane NM, Leary S, et al
    Adaptation to HLA-associated immune pressure over the course of HIV infection and in circulating HIV-1 strains.
    PLoS Pathog. 2022;18:e1010965.
    PubMed         Abstract available


    Vaccine

  57. SULLIVAN KM, Farraye FA, Winthrop KL, Willer DO, et al
    Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions.
    Vaccine. 2022 Nov 29:S0264-410X(22)01329-9. doi: 10.1016/j.vaccine.2022.
    PubMed         Abstract available

  58. TRACEY G, Olivia B, Jean M, Megan H, et al
    Why does gender matter for immunization?
    Vaccine. 2022 Dec 10:S0264-410X(22)01495-5. doi: 10.1016/j.vaccine.2022.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: